Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
Episode 29: ORIGAMI 4 with Barbara Burtness
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
In this episode we're delighted to welcome Professor Barbara Burtness from Yale School of Medicine to discuss the exciting results of the OrigAMI-4 trial and what they could mean for the future of head and neck cancer treatment.
We explore the emerging role of amivantamab. Barbara takes us through the rationale behind the study, its encouraging clinical results, and the potential implications for patients who have progressed despite immunotherapy and chemotherapy.
adbl_web_anon_alc_button_suppression_t1
No reviews yet